| scholarly article | Q13442814 |
| P50 | author | Kyriakie Sarafoglou | Q83683158 |
| P2093 | author name string | Anna Petryk | |
| James S Hodges | |||
| Aaron S Kelly | |||
| Brandon M Nathan | |||
| Belen Sanchez | |||
| Donald Dengel | |||
| Alyssa Halper | |||
| P2860 | cites work | Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline | Q24614223 |
| The role of estrogen and androgen receptors in bone health and disease | Q27008878 | ||
| CDC growth charts: United States | Q29615833 | ||
| Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children | Q33526749 | ||
| Visceral fat is a negative predictor of bone density measures in obese adolescent girls | Q33738672 | ||
| Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity | Q34014004 | ||
| Bone mineral status in Egyptian children with classic congenital adrenal hyperplasia. A single-center study from Upper Egypt | Q34229053 | ||
| Importance of android/gynoid fat ratio in predicting metabolic and cardiovascular disease risk in normal weight as well as overweight and obese children | Q34273546 | ||
| The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women | Q34646914 | ||
| Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression | Q35169193 | ||
| Direct effects of sex steroid hormones on adipose tissues and obesity | Q35905509 | ||
| Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency | Q35916502 | ||
| Dual-energy X-ray absorptiometry for quantification of visceral fat. | Q35990549 | ||
| Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia | Q36442459 | ||
| DXA estimates of fat in abdominal, trunk and hip regions varies by ethnicity in men. | Q36718514 | ||
| Bone mineral status in children with congenital adrenal hyperplasia | Q36940123 | ||
| Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia | Q37023031 | ||
| Bone mineral density in children and adolescents with congenital adrenal hyperplasia | Q37664689 | ||
| Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. | Q38195432 | ||
| Cardiovascular health, growth and gonadal function in children and adolescents with congenital adrenal hyperplasia | Q39038556 | ||
| Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency | Q40713923 | ||
| Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density | Q44637645 | ||
| Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency. | Q46135331 | ||
| Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy | Q46146396 | ||
| Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. | Q46292384 | ||
| Height, bone mineral density and bone markers in congenital adrenal hyperplasia | Q47207903 | ||
| Bone density in young patients with congenital adrenal hyperplasia. | Q51020570 | ||
| Visceral adipose tissue measured by DXA correlates with measurement by CT and is associated with cardiometabolic risk factors in children. | Q51319676 | ||
| Bone mineral density and body composition in congenital adrenal hyperplasia | Q71869647 | ||
| Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro | Q73120983 | ||
| The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia | Q73941194 | ||
| Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells | Q78181001 | ||
| Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia | Q85941507 | ||
| Bone mineral density and vitamin D status in children and adolescents with congenital adrenal hyperplasia | Q86453079 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 813-819 | |
| P577 | publication date | 2018-03-24 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Bone mineral density and body composition in children with congenital adrenal hyperplasia | |
| P478 | volume | 88 |
| Q64054707 | Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency |
| Q64267480 | Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency |
| Q59810696 | Pediatric Adrenal Insufficiency: Diagnosis, Management, and New Therapies |
Search more.